Szpitale Pomorskie spółka z ograniczoną odpowiedzialnością

Gdynia 81-519

1 studies enrolling now · 5 studies all time

What they study most

Chemotherapeutic Toxicity, Colorectal Cancer Metastatic, Endometrial Cancer, Myelosuppression-Adult, Refractory Diffuse Large B-Cell Lymphoma, Refractory Follicular Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma, Relapsed Follicular Lymphoma, Small Cell Lung Cancer

Studies at this site

• Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer — Recruiting now
• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer — Completed
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): — Stopped early
• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma — Stopped early